Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Molecular Medicine is Scopus-indexed (Q1, CiteScore 8.6), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer Science and Business Media Deutschland GmbH.
Checked against the index lists dated .
ISSN 0946-2716Verify ISSN ↗1432-1440Verify ISSN ↗
Publisher: Springer Science and Business Media Deutschland GmbH
Cost to publish: About US$4,390 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics (clinical) | 14 / 100 | 86th | Q1 |
| Drug Discovery | 32 / 161 | 80th | Q1 |
| Molecular Medicine | 45 / 179 | 75th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1995–present (also 1980–1981, 1976–1978), best quartile Q1, CiteScore 8.6.
Journal of Molecular Medicine is Q1 in Genetics (clinical) (rank 14 of 100), Q1 in Drug Discovery (rank 32 of 161) and Q1 in Molecular Medicine (rank 45 of 179), by CiteScore 2025.
Journal of Molecular Medicine is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 8.6, which places it in quartile Q1 at the 86th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.401, quartile Q1, with an H-index of 167.
The publisher lists an article processing charge of about US$4,390 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Molecular Medicine is published by Springer Science and Business Media Deutschland GmbH. Its print ISSN is 0946-2716 and its online ISSN is 1432-1440.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Molecular Medicine has an h-index of 201 and a 2-year mean of 4.9 citations per paper (OpenAlex). Its Scopus CiteScore is 8.6, quartile Q1. On 2-year citations it ranks #11 of 99 Scopus journals in Genetics (clinical).
Journal of Molecular Medicine published 116 papers in 2025; its busiest recent year was 2021 with 154. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from China (35.8%), United States (10%) and Germany (7.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 16 retracted papers are recorded (0.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.